Research Articles | Page 3 | Aplastic Anemia & MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms Jul 2019 Surgical Pathology Clinic myelodysplastic syndromes (MDS)
Impaired proliferative potential of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway Mar 2014 Stem Cells Dev myelodysplastic syndromes (MDS)
Aplastic anemia: what have we learned from animal models and from the clinic. Jun 2013 Semin Hematol aplastic anemia
Detection of paroxysmal nocturnal hemoglobinuria (PNH) in bone marrow aspirates Jan 2019 Semin Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond Sep 2017 Semin Hematol myelodysplastic syndromes (MDS)
The Non-transplant Treatment of Myelodysplastic Syndromes-What's on the Horizon? Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Optimizing the use of hypomethylating agents in myelodysplastic syndromes: Selecting the candidate, predicting the response, and enhancing the activity Sep 2017 Semin Hematol myelodysplastic syndromes (MDS)
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndromes Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Increasing the effectiveness of hematopoiesis in myelodysplastic syndromes: erythropoiesis-stimulating agents and transforming growth factor-β superfamily inhibitors Sep 2017 Semin Hematol myelodysplastic syndromes (MDS)
Clinical results with the DNA hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in patients with myelodysplastic syndromes: an update Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)